Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle Preparation with Levulan PDT for Actinic Keratosis
NCT02632110Phase 2Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- Mar 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aminolevulinic acid 10% gel in actinic keratosis (AK) (10 arms), sponsored by DUSA Pharmaceuticals. Primary endpoint: Complete Clearance Rate at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02632110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632110.